Clinical Trial Update: Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS]) [Phase 2]

View source ↗

Summary

Phase 2 trial update for Zatolmilast (BPN14770) in PPP2R5D-related neurodevelopmental disorder (Jordan's syndrome), noting the study is active but not currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ppp2r5d-related Neurodevelopmental Disorder

Drugs mentioned

• Zatolmilast (BPN14770)

Snippet

Sponsor: Shionogi | Conditions: Jordan's Syndrome, PPP2R5D Neurodevelopmental Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING